DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Moayyedi P, Eikelboom JW, Bosch J. et al. COMPASS Investigators.
Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin.
Gastroenterology 2019;
157 (03) 682.e2-691.e2
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.